ArticleCurrent neurovascular research2026
Bioinformatics Analysis of ZDHHC-protein Acyltransferase for Predicting the Rupture of Aneurysmal Subarachnoid Hemorrhage.
Article in Current neurovascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The emerging role of ZDHHC9 in cancer: from protein palmitoylation to tumor progression and immune regulation.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionIntracranial aneurysms (IAs) can cause life-threatening subarachnoid hemorrhage upon rupture, yet their molecular mechanisms remain poorly understood. Proteins encoded by the ZDHHC genes mediate protein palmitoylation and are involved in brain injury processes, but their relationship with IA rupture is unclear.
methodsThis study utilized gene expression profiles from the Gene Expression Omnibus (GEO) database for unruptured intracranial aneurysms (UIAs) and ruptured intracranial aneurysms (RIAs) using two-tailed Student's t-test, and univariate and multivariate logistic regression analyses. A predictive risk model and nomogram for IA rupture were constructed using machine learning methods, and the model's accuracy was evaluated with calibration curves, C-index, clinical decision curves, and clinical impact curves. Receiver operating characteristic (ROC) curves demonstrated good diagnostic performance in both training and validation datasets. Additionally, a rat SAH model was used to validate the increased expression of the six ZDHHC-encoded proteins post-SAH via Western blotting.
resultsSix high-risk genes associated with IA rupture were identified: ZDHHC3, ZDHHC5, ZDHHC7, ZDHHC8, ZDHHC9, and ZDHHC13. DISCUSSION: ZDHHC family genes can serve as potential biomarkers for IA rupture, but their relationship with prognosis still needs further investigation.
conclusionZDHHC family genes can predict IA rupture and hold promise as clinical biomarkers, which also suggests the critical role of palmitoylation modification in the pathological process of SAH.
Indexed as
Identifiers
41735222What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.